Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
DESOGESTREL
Organon (Ireland) Limited
75 Microgram
Film Coated Tablet
1998-08-14
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0061/027/001 Case No: 2037806 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to ORGANON (IRELAND) LIMITED DRYNAM ROAD, SWORDS, CO. DUBLIN, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product CERAZETTE 75 MICROGRAM FILM-COATED TABLET The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 12/12/2007. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 13/03/2008_ _CRN 2037806_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cerazette 75 microgram film-coated tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 75 microgram desogestrel. Excipient lactose < 65mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet The tablet is white, round, biconvex and 5 mm in diameter. On one side it is coded KV above 2 and on the reverse side Organon*. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Contraception. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION HOW TO TAKE CERAZETTE: Tablets must be taken every day at about the same time so that the interval between two tablets always is 24 hours. Read the complete document